Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Long Term Trial on Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

NCT00854919 is registered in ClinicalTrials.gov with Osaka City University as lead sponsor.

NCT NCT00854919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00854919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Long Term Trial on Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Lead sponsor
Osaka City University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
December 31, 2007
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ssri-refractory obsessive-compulsive disorder